25 May 2013
Keywords: ucb, gains, swiss, approval, keppra, pharma, gained
Article | 12 April 2000
UCB Pharma has gained approval from the Swiss Health Authority for itsantiepileptic Keppra (levetiracetam). The company also notes that a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.